UPstart Program Selects Clinlogix as a CRO Partner


Applied Clinical Trials

Clinlogix, a clinical research organization located just outside Philadelphia, is proud to announce its selection by the UPstart program at the University of Pennsylvania as a preferred Clinical Research Organization.   The UPstart program strives to maximize the potential of University of Pennsylvania research and technologies through the creation and stimulus of entrepreneurial endeavors. Clinlogix is extremely excited about this partnership, which allows the company to leverage its extensive clinical and regulatory experience and transfer that knowledge to a variety of UPSTART projects.

Michael Poisel, UPstart Director, stated that “So much of the success of our UPstart companies is determined by the involvement of our many partners along the way. We are excited to have the Clinlogix team join us and add their significant experience in the development of these exciting young businesses.”

JeanMarie Markham, President and CEO of Clinlogix, stated that “The relevance of this relationship is the recognition that early stage, academic research is beginning to think beyond its borders.  Historically there have been challenges in the process of ‘translating’ academic research and concepts into a ‘commercial’ product and viable company.  The selection of Clinlogix by UPstart reflects the organization’s forward thinking.  UPstart is beginning with the end in mind.  With limited financial resources, the goal is to make the most impact by developing viable strategic development plans. “

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.